Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2022 Oct;9(5):3483-3495.
doi: 10.1002/ehf2.14085. Epub 2022 Jul 26.

Prognostic value of various markers in recovery from peripartum cardiomyopathy: a systematic review and meta-analysis

Affiliations
Meta-Analysis

Prognostic value of various markers in recovery from peripartum cardiomyopathy: a systematic review and meta-analysis

Alireza Hosseinpour et al. ESC Heart Fail. 2022 Oct.

Abstract

Aims: The aetiology of peripartum cardiomyopathy (PPCM) is still not clear, and it is unknown who would recover from PPCM. In this meta-analysis, for the first time, we aimed to explore the prognostic value of potential baseline factors that may help predict recovery in patients with PPCM.

Methods: A systematic approach following the Meta-analysis of Observational Studies in Epidemiology guideline was taken by using appropriate keywords in PubMed, Scopus, and Embase databases. Studies that had compared different clinical and paraclinical markers at the time of diagnosis related to cardiovascular function between recovered and non-recovered patients with PPCM were included. To find potential predictors of recovery, the odds ratio (OR) was calculated for different parameters using the random-effects model.

Results: Eighteen cohort studies including 1047 patients with PPCM were enrolled. Six markers out of the 11 potentially eligible markers were associated with PPCM recovery. Baseline echocardiographic parameters [left ventricular ejection fraction (LVEF) (OR = 4.84 [2.53; 9.26]), left ventricular end-diastolic diameter (OR = 3.67 [2.58; 5.23]), left ventricular end-systolic diameter (OR = 3.99 [2.27; 7.02]), and fractional shortening (OR = 6.14 [1.81; 20.85])] were strong predictors of PPCM recovery. Systolic blood pressure (OR = 2.16 [1.38; 3.38]) and diastolic blood pressure (OR = 2.06 [1.07; 3.96]) at diagnosis were also associated with recovery.

Conclusions: Patients with PPCM who have a higher baseline LVEF, lower left ventricular diameters, and higher blood pressure levels have a greater chance to recover from PPCM.

Keywords: Heart failure; Left ventricular recovery; Peripartum cardiomyopathy; Predictors of recovery.

PubMed Disclaimer

Conflict of interest statement

None declared.

Figures

Figure 1
Figure 1
PRISMA flow diagram of the search strategy.
Figure 2
Figure 2
Forest plots of the correlation between echocardiographic parameters [(A) LVEF, (B) LVEDDa, (C) LVESDa, and (D) FS] and peripartum cardiomyopathy recovery (LVEF, left ventricular ejection fraction; LVEDD, left ventricular end‐diastolic diameter; LVESD, left ventricular end‐systolic diameter; FS, fractional shortening). aThe mentioned forest plots were reversed to the odds ratio of the non‐recovery group for easier interpretation.
Figure 3
Figure 3
Forest plots of the correlation between baseline blood pressure and heart rates [(A) SBP, (B) DBP, and (C) heart ratea) and peripartum cardiomyopathy recovery (SBP, systolic blood pressure; and DBP, diastolic blood pressure). aThe mentioned forest plots were reversed to the odds ratio of the non‐recovery group for easier interpretation.
Figure 4
Figure 4
Forest plots of the correlation between (A) hypertensive disorders, (B) diabetes mellitus,a (C) LV thrombus,a and (D) NYHA FCa and peripartum cardiomyopathy recovery (LV thrombus, left ventricular thrombus; and NYHA FC, New York Heart Association functional class). aThe mentioned forest plots were reversed to the odds ratio of the non‐recovery group for easier interpretation.

References

    1. Sliwa K, Hilfiker‐Kleiner D, Petrie MC, Mebazaa A, Pieske B, Buchmann E, Regitz‐Zagrosek V, Schaufelberger M, Tavazzi L, van Veldhuisen DJ, Watkins H, Shah AJ, Seferovic PM, Elkayam U, Pankuweit S, Papp Z, Mouquet F, McMurray JJ. Current state of knowledge on aetiology, diagnosis, management, and therapy of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology working group on peripartum cardiomyopathy. Eur J Heart Fail. 2010; 12: 767–778. - PubMed
    1. van der Meer P, Gaggin HK, Dec GW. ACC/AHA versus ESC guidelines on heart failure: JACC guideline comparison. J Am Coll Cardiol. 2019; 73: 2756–2768. - PubMed
    1. Isogai T, Kamiya CA. Worldwide incidence of peripartum cardiomyopathy and overall maternal mortality. Int Heart J. 2019; 60: 503–511. - PubMed
    1. Arany Z, Elkayam U. Peripartum cardiomyopathy. Circulation. 2016; 133: 1397–1409. - PubMed
    1. Bello N, Rendon ISH, Arany Z. The relationship between pre‐eclampsia and peripartum cardiomyopathy: a systematic review and meta‐analysis. J Am Coll Cardiol. 2013; 62: 1715–1723. - PMC - PubMed